Eversheds Sutherland advises PHSE Group on the acquisition of TKS

Eversheds Sutherland has advised MFI (Moving Forward International GmbH), part of the PHSE Group, on its acquisition of TKS, a German specialist transport company focused on dangerous goods, radioactive materials and radiopharmaceutical products.

With this transaction, the PHSE Group reinforces its position as a leading specialist in radiopharmaceutical-tical logistics, a critical sector where highly sensitive oncology therapeutics and nuclear medicine diagnostics demand absolute precision and uncompromised speed in delivery.

TKS brings significant operational capacity to MFI, with experienced drivers and administrative staff, and a fleet of specialized vehicles. The company is strategically headquartered near Frankfurt Airport, Germany’s principal aviation hub and one of Europe’s largest cargo centres, providing optimal connectivity for time-critical pharmaceutical shipments.

With this transaction, the PHSE Group reinforces its position as a leading specialist in radiopharmaceutical-tical logistics, a critical sector where highly sensitive oncology therapeutics and nuclear medicine diagnostics demand absolute precision and uncompromised speed in delivery.

The Eversheds Sutherland team was led by Sandra Link (Partner, Corporate M&A, Frankfurt) and included Tim Flaeper (Associate, Corporate M&A, Frankfurt) and Sabrina Rübsam (Associate, Labour Law, Frankfurt).